EP-129 - TENDÊNCIAS HISTÓRICAS NA PREVALÊNCIA DE LEVEDURAS RARAS ASSOCIADAS À INFECÇÕES DE CORRENTE SANGUÍNEA (ICSS) NO BRASIL - DADOS PRELIMINARES

Carolina Palamin Buonafine(Universidade Federal de São Paulo), Arnaldo Lopes Colombo(Universidade Federal de São Paulo), Valério Rodrigues Aquino(Universidade Federal do Rio Grande do Sul), Caroline Agnelli(Universidade Federal de São Paulo), Teresa Sukiennik(Santa Casa de Misericórdia de Marília), Elaine Cristina Francisco(Universidade Federal do Paraná), Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), Regielly Caroline Raimundo Cognialli(Hospital de Clínicas Universidade Federal do Paraná), Thaís Guimarães(Hospital do Servidor Público Estadual)
The Brazilian Journal of Infectious Diseases
October 1, 2024
10.1016/j.bjid.2024.104053
Cited by 0

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Simultaneous Emergence of Multidrug-Resistant <i>Candida auris</i> on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
|Clinical Infectious Diseases|2016|1.6k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
|The Lancet|2022|467